Among them, nearly 80% of the in vitro diagnostic companies reported good performance, and 11 companies saw a year-on-year increase of more than 100%, including Jimin Medical, Rejing Bio, Xinkaiyuan, Jiu'an Medical, Mingde Bio, Wantai Bio, and Oriental Bio .
[Pharmaceutical Network Industry News] On the evening of April 14, while disclosing the 2021 annual report, the in vitro diagnostic company Shuo Shi Bio also announced the annual dividend plan, which plans
Recently, Aide Bio announced that it has reached a global companion diagnostic cooperation with AstraZeneca, an innovative tumor pharmaceutical company, and the cooperation market has expanded from China to global markets such as Japan and the European Union .
Diagnosis and screening methods for colorectal cancer (CRC) include fecal occult blood test (FOBT), serum carcinoembryonic antigen (SCEA), sigmoidoscopy and colonoscopy, each of which has advantages and disadvantages .
[Pharmaceutical Network Market Analysis] In vitro diagnosis (IVD) refers to products and services that obtain clinical diagnostic information by testing human samples (blood, body fluids, tissues, etc.
/> Professor Tang Qi mentioned in particular: "Whether it is new imaging technology or genetic testing, it is conducive to more accurate diagnosis and treatment, which is also the progress of clinicians in precision treatment
The source of this page with content of products and services is from Internet,
which doesn't represent ECHEMI's opinion. If you have any queries, please write
to firstname.lastname@example.org. It will be replied within 5 days.
Moreover, if you find any instances of plagiarism from the page,
please send email to email@example.com with relevant evidence.